RE: UK investor magazine5 Jan 2025 15:38
Mozak
"I’m referring to ARgo Blockchain, the Bitcoin Miner.
Bitcoin!! FAB is biotech. Arb trading is where traders play the difference in price between US and UK.
Can you please post a link to where FAB have said they are dual listing?????
Plus, look at evidence of other companies, inc biotech, who have dual or solely listed on Nasdaq/AIM over past 3/4 years.
SLN, biotech - listed years ago, high was $28 and has fallen since on company/sector newsflow... currently $7.4, down 75%
Trmr (now nexn), Ad tech dual listed 3.5 years ago. As soon as they dual listed, the shares started falling - I posted company/sector newsflow and warned of the red flags. The shares dual listed 800p(UK price), crashed to around 150p on profit warnings. Currently, as Nexn, around 400p.
More recently, where shares crashed 30-40% on news of US listing, dual or sole.
AHT - announced US listing last month - The shares crashed around 6400p to around 5000p, 30% down
Polb, another biotech - announced dual listing just last week. The shares crashed 40% from 7p to 4p.
That's 4 have done crashed around avg of 50% since announcing they are dual/solely listing.
Dual listing causing anxiety as any news announced in US, when UK market closed, will impact the sp and UK investors will not be able to trade.
In majority of cases, the US isn't the dream that some think it is.